Bristol-Myers Squibb Company

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 06 Sep 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

1,000,000€ - 1,249,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

4.55 Fte (10)

Lobbyists with EP accreditation

7

High-level Commission meetings

2

Lobbying Costs over the years

  • Info

    Bristol-Myers Squibb Company   (BMS)

    EU Transparency Register

    04437556781-76 First registered on 26 Sep 2011

    Goals / Remit

    Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

    Main EU files targeted

    Implementation of the Pharmaceutical Strategy for Europe (including Regulation 2023/0131 for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency and Directive 2023/0123 on the Union code relating to medicinal products for human use), Fees payable to the European Medicines Agency, Revision of the OMP and Paediatric Regulations, implementation of the EU Regulation on HTA, Clinical Trials legislation, Europe's Beating Cancer Plan, Regulation on a European Health Data Space, Access to medicines, Standards of quality and safety for substances of human origin intended for human application, IP Action, Plan, EU Reference networks, cross-country collaboration on pricing and access to medicines, European Semester, trade agreements, Transatlantic Data flows, GDPR, data analytics including AI, a new transatlantic agenda, Healthier Together (EU NCD Initiative)

    Address

    Head Office
    Route 206Province Line Road
    Princeton, New Jersey 08543
    UNITED STATES
    EU Office
    Rue du TrĂ´ne 108
    Ixelles 1050
    BELGIUM

    Website

  • People

    Total lobbyists declared

    10

    Employment timeLobbyists
    100%2
    75%1
    50%2
    25%2
    10%3

    Lobbyists (Full time equivalent)

    4.55

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    7 accreditations were / are live (in bold) for the selected state of 22 Nov 2024

    Name Start date End Date
    Dimitri Pouradier-Duteil 10 Oct 2024 10 Oct 2025
    Katerina VALKOVA 11 Oct 2024 11 Oct 2025
    Claire ALBANO 01 Oct 2024 01 Oct 2025
    Silviu POPA 23 Sep 2024 23 Sep 2025
    Pieter-Jan Mattheus 08 Oct 2024 08 Oct 2025
    Douglas GREGORY 01 Jun 2024 01 Jun 2025
    Bernard Mallee 16 Apr 2024 16 Apr 2026
    Claire ALBANO 15 Nov 2023 04 Oct 2024
    Sara Lynn MARTIN 10 Nov 2023 04 Oct 2024
    Silviu POPA 05 Oct 2023 04 Oct 2024
    Katerina VALKOVA 13 Feb 2024 04 Oct 2024
    Pieter Jan MATTHEUS 05 Oct 2023 04 Oct 2024
    Douglas GREGORY 13 Jul 2023 05 Jun 2024
    Dimitri Pouradier Duteil 06 Oct 2023 04 Oct 2024
    Emmanuel CHANTELOT 21 Oct 2023 04 Oct 2024
    Bernard Mallee 13 Apr 2023 26 Apr 2024
    Claire ALBANO 19 Nov 2022 15 Nov 2023
    Mr Adam David PARNABY 17 Nov 2022 13 Apr 2023
    Sara Lynn MARTIN 16 Nov 2022 10 Nov 2023
    Emmanuel CHANTELOT 27 Oct 2022 21 Oct 2023
    Pieter Jan MATTHEUS 14 Oct 2022 05 Oct 2023
    Silviu POPA 13 Oct 2022 05 Oct 2023
    Dimitri Pouradier Duteil 12 Oct 2022 06 Oct 2023
    Silviu POPA 28 Oct 2021 13 Oct 2022
    Katerina VALKOVA 06 Oct 2022 06 Oct 2023
    Douglas GREGORY 22 Jun 2022 22 Jun 2023
    Ms Anneke SANDERS 30 Mar 2022 02 Apr 2022
    Claire ALBANO 18 Dec 2021 19 Nov 2022
    Pieter Jan MATTHEUS 19 Nov 2021 14 Oct 2022
    Emmanuel CHANTELOT 04 Nov 2021 27 Oct 2022
    Silviu POPA 28 Oct 2021 11 Oct 2022
    Ms Sara MARTIN 28 Oct 2021 28 Oct 2022
    Dimitri Pouradier Duteil 28 Oct 2021 12 Oct 2022
    Douglas GREGORY 17 Jun 2021 17 Jun 2022
    Douglas GREGORY 24 Jun 2020 17 Jun 2021
    Ms Titta Rosvall-Puplett 15 Feb 2020 01 Mar 2021
    Dimitri Pouradier Duteil 15 Feb 2020 01 Mar 2021
    Ms Sara MARTIN 15 Feb 2020 01 Mar 2021
    Ms Sara MARTIN 16 Feb 2019 15 Feb 2020
    Ms Titta Rosvall-Puplett 13 Feb 2019 13 Feb 2020
    Dimitri Pouradier Duteil 13 Feb 2019 13 Feb 2020
    Laurence LECLERCQ 13 Feb 2019 13 Feb 2020
    Laurence LECLERCQ 16 Feb 2018 13 Feb 2019
    Ms Titta Rosvall-Puplett 15 Feb 2018 13 Feb 2019
    Ms Danuta Rydlewska 15 Feb 2018 16 Feb 2019
    Dimitri Pouradier Duteil 15 Feb 2018 13 Feb 2019
    Ms Titta Rosvall-Puplett 20 Mar 2017 15 Feb 2018
    Ms Danuta Rydlewska 20 Mar 2017 15 Feb 2018
    Dimitri Pouradier Duteil 20 Mar 2017 15 Feb 2018
    Mr Martin Whitehead 05 Sep 2016 01 Sep 2017
    Ms Danuta Rydlewska 30 Mar 2016 21 Mar 2017
    Ms Titta Rosvall-Puplett 24 Mar 2016 10 Mar 2017
    Dimitri Pouradier Duteil 13 Feb 2016 12 Feb 2017
    Anouk De Vroey 25 Sep 2015 23 Sep 2016
    Ms Titta Rosvall-Puplett 11 Feb 2015 05 Feb 2016
    Anouk De Vroey 16 Sep 2014 12 Sep 2015
    Anouk De Vroey 16 Sep 2014 27 Jan 2015
    Mr Jean-Louis Roux 16 Sep 2014 12 Sep 2015
    Mr Jean-Louis Roux 01 Oct 2013 16 Sep 2014
    Ms Athanasia Kanli 28 Sep 2013 27 Sep 2014
    Anouk De Vroey 26 Sep 2013 16 Sep 2014
    Anouk De Vroey 28 Nov 2011 01 Nov 2012

    Complementary Information

    1 Senior VP Global Policy and International Government Affairs (10%)
    1 Senior Director, EU Government Affairs Strategy and Excellence (90%)
    1 Director European Government Affairs (50%)
    1 Associate Director, European Public Policy (90%)
    1 Director, Government Engagement and Partnerships, Europe (50%)
    1 Director, International Government Affairs Excellence (10%)
    1 Associate Director, Policy & Government Affairs - Intercontinental (10%)
    1 Senior Director, Health Policy, Strategy and Economics (25%)
    1 Senior Director, Global Policy Partnerships & Alliance Development (10%)
    1 Director, International Policy Communications (50%)

    Other BMS employees contributing to EU policy-shaping through participation in trade association working groups are accounted for in the total expenses, but not in the FTE above. The above covers only Brussels-based policy & government affairs staff.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    European Federation of Pharmaceutical Industries and Associations (EFPIA), EFPIA Oncology Platform, EFPIA Cardiovascular Health Platform, EFPIA Alzheimer's Platform, DigitalEurope, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Friends of Europe, American Chamber of Commerce to the EU, American European Community Association (AECA), American Chamber of Commerce Turkey, European Patients' Forum, EURORDIS, TRANSFORM Alliance

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    1,000,000€ - 1,249,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    apco 50,000€ - 99,999€
    eppa 25,000€ - 49,999€
    dentons global advisors 400,000€ - 499,999€
    zn consulting 100,000€ - 199,999€
    acumen public affairs 50,000€ - 99,999€

    Intermediaries for current year

    Name
    acumen public affairs
    zn consulting
    apco
    dga interel

    Closed year Costs

    1,000,000€ - 1,249,999€

    Other financial info

    Bristol-Myers Squibb Belgium has a corporate sponsorship with the Alliance of Liberals and Democrats for Europe for 2023. The amount of that corporate sponsorship is 18,000 euros and it is treated as a political donation.

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    BMS is a member and main sponsor of the All.Can initiative https://www.all-can.org/about-us/
    Towards sustainable Cancer Care : Reducing Inefficiencies, improving outcomes - A policy Report from the All.Can initiative - January 2017

    Blood and Beyond https://bloodandbeyond.com/
    including launch event held on Thursday, March 26, 2020 and report on "Rethinking Blood Use in Europe to Improve Outcomes for" published on March 26, 2020

    Cardiomyopathies Matter cardiomyopathiesmatter.org
    Including launch event on November 15, 2022 in the European Parliament and report published the same day.

    BMS EU Policy Twitter handle (@BMS_EUpolicy) and BMS EU policy website (www.eupolicy.bms.com) launched in January 2023.

    Other activities

    None declared

  • Meetings

    Meetings

    2 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 08 Dec 2016 Location Brussels
      Subject Innovation and investment
      Cabinet Cabinet of Vice-President Jyrki Katainen
      Portfolio Jobs, Growth, Investment and Competitiveness
      Attending
      • Juho Romakkaniemi (Cabinet member)
    • Date 08 Dec 2016 Location Brussels
      Subject HTA, HSPA
      Cabinet Cabinet of Commissioner Vytenis Andriukaitis
      Portfolio Health &amp; Food Safety
      Attending
      • Annika Nowak (Cabinet member)
Download this datacard